The pump currently in development allows users to change sites without a phone—potentially reshaping the tubeless landscape and pushing rivals to move faster.
Smartwatch bolusing, advanced occlusion detection, and CGM integration set the stage for Sequel Med Tech’s game-changing debut.
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Dexcom's latest CGM is now supported on the Omnipod 5 iPhone App.
Tandem Diabetes is already telling patients its smartphone app to control the Mobi insulin pump will arrive by the end of 2025.
After three years with Omnipod, a tubed pump taught me something new about tech—and myself
Tandem’s SteadiSet just received FDA 510(k) clearance—and it could soon bring 7-day wear to more insulin pump users.
The switch from a tubeless to a tubed pump had its challenges.
Dexcom G7 integration is finally coming to the Omnipod 5 iPhone users.
Insulet has a chance to take the Omnipod tubeless insulin pump to the next level with these hardware and software upgrades.
While Omnipod 5 offers less customization than DIY apps, it has some impressive advantages.
